
Charles Atkinson
Examiner (ID: 13902)
| Most Active Art Unit | 2306 |
| Art Unit(s) | 2305, 2604, 2307, 2413, 2306, 2313 |
| Total Applications | 1186 |
| Issued Applications | 1116 |
| Pending Applications | 2 |
| Abandoned Applications | 68 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 1213057
[patent_doc_number] => 06710031
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-03-23
[patent_title] => 'Protein having antithrombotic activity and method for producing the same'
[patent_app_type] => B2
[patent_app_number] => 09/969763
[patent_app_country] => US
[patent_app_date] => 2001-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 15
[patent_no_of_words] => 22065
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 281
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/710/06710031.pdf
[firstpage_image] =>[orig_patent_app_number] => 09969763
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/969763 | Protein having antithrombotic activity and method for producing the same | Oct 3, 2001 | Issued |
Array
(
[id] => 935444
[patent_doc_number] => 06974793
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-12-13
[patent_title] => 'Method for treating primary hyperparathyroid disorders'
[patent_app_type] => utility
[patent_app_number] => 09/971869
[patent_app_country] => US
[patent_app_date] => 2001-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11524
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/974/06974793.pdf
[firstpage_image] =>[orig_patent_app_number] => 09971869
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/971869 | Method for treating primary hyperparathyroid disorders | Oct 3, 2001 | Issued |
Array
(
[id] => 6711549
[patent_doc_number] => 20030171298
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-11
[patent_title] => 'Retroinverso polypeptides that mimic or inhibit thrombospondin'
[patent_app_type] => new
[patent_app_number] => 10/042696
[patent_app_country] => US
[patent_app_date] => 2001-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 19055
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20030171298.pdf
[firstpage_image] =>[orig_patent_app_number] => 10042696
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/042696 | Retroinverso polypeptides that mimic or inhibit thrombospondin | Oct 2, 2001 | Abandoned |
Array
(
[id] => 5787283
[patent_doc_number] => 20020160496
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-31
[patent_title] => 'Isolated GRP94 ligand binding domain polypeptide and nucleic acid encoding same, and screening methods employing same'
[patent_app_type] => new
[patent_app_number] => 09/968436
[patent_app_country] => US
[patent_app_date] => 2001-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 51152
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20020160496.pdf
[firstpage_image] =>[orig_patent_app_number] => 09968436
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/968436 | Isolated GRP94 ligand binding domain polypeptide and nucleic acid encoding same, and screening methods employing same | Sep 30, 2001 | Issued |
| 09/719755 | Interaction of p27(kip1) with fkbp-12 | Sep 20, 2001 | Abandoned |
Array
(
[id] => 6438900
[patent_doc_number] => 20020128203
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-12
[patent_title] => 'Methods of identifying inhibitory compounds and uses thereof'
[patent_app_type] => new
[patent_app_number] => 09/956522
[patent_app_country] => US
[patent_app_date] => 2001-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9614
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0128/20020128203.pdf
[firstpage_image] =>[orig_patent_app_number] => 09956522
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/956522 | Methods of identifying inhibitory compounds and uses thereof | Sep 18, 2001 | Abandoned |
Array
(
[id] => 6158608
[patent_doc_number] => 20020147131
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-10
[patent_title] => 'Metabolic intervention with GLP-1 to improve the function of ischemic and reperfused skeletal muscle tissue'
[patent_app_type] => new
[patent_app_number] => 09/953021
[patent_app_country] => US
[patent_app_date] => 2001-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5859
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0147/20020147131.pdf
[firstpage_image] =>[orig_patent_app_number] => 09953021
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/953021 | Metabolic intervention with GLP-1 to improve the function of ischemic and reperfused skeletal muscle tissue | Sep 10, 2001 | Abandoned |
Array
(
[id] => 6664034
[patent_doc_number] => 20030203360
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-30
[patent_title] => 'Methods for identifying products employing gene expression'
[patent_app_type] => new
[patent_app_number] => 09/950312
[patent_app_country] => US
[patent_app_date] => 2001-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11348
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20030203360.pdf
[firstpage_image] =>[orig_patent_app_number] => 09950312
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/950312 | Methods for identifying products employing gene expression | Sep 9, 2001 | Abandoned |
Array
(
[id] => 6158755
[patent_doc_number] => 20020147144
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-10
[patent_title] => 'Casein derived peptides and uses thereof in therapy'
[patent_app_type] => new
[patent_app_number] => 09/942121
[patent_app_country] => US
[patent_app_date] => 2001-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 28065
[patent_no_of_claims] => 283
[patent_no_of_ind_claims] => 73
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0147/20020147144.pdf
[firstpage_image] =>[orig_patent_app_number] => 09942121
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/942121 | Casein derived peptides and uses thereof in therapy | Aug 29, 2001 | Abandoned |
Array
(
[id] => 1345686
[patent_doc_number] => 06582968
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-06-24
[patent_title] => 'Paramagnetic and active analogue (EMP-2) of melanocyte stimulating hormone containing amino acid-type stable free radical'
[patent_app_type] => B2
[patent_app_number] => 09/935760
[patent_app_country] => US
[patent_app_date] => 2001-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 7
[patent_no_of_words] => 3585
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/582/06582968.pdf
[firstpage_image] =>[orig_patent_app_number] => 09935760
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/935760 | Paramagnetic and active analogue (EMP-2) of melanocyte stimulating hormone containing amino acid-type stable free radical | Aug 23, 2001 | Issued |
| 09/914343 | Method for preparing an albumin isolate from a substance containing albumin | Aug 21, 2001 | Abandoned |
Array
(
[id] => 1002445
[patent_doc_number] => 06908899
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-06-21
[patent_title] => 'Pro-inflammatory fibrinopeptide'
[patent_app_type] => utility
[patent_app_number] => 09/931009
[patent_app_country] => US
[patent_app_date] => 2001-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 7
[patent_no_of_words] => 7120
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/908/06908899.pdf
[firstpage_image] =>[orig_patent_app_number] => 09931009
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/931009 | Pro-inflammatory fibrinopeptide | Aug 16, 2001 | Issued |
Array
(
[id] => 7625472
[patent_doc_number] => 06723697
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-04-20
[patent_title] => 'IL-16 antagonists'
[patent_app_type] => B2
[patent_app_number] => 09/929922
[patent_app_country] => US
[patent_app_date] => 2001-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 17
[patent_no_of_words] => 15090
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/723/06723697.pdf
[firstpage_image] =>[orig_patent_app_number] => 09929922
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/929922 | IL-16 antagonists | Aug 14, 2001 | Issued |
Array
(
[id] => 1059756
[patent_doc_number] => 06852846
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-02-08
[patent_title] => 'Viral amplification of recombinant messenger RNA in transgenic plants'
[patent_app_type] => utility
[patent_app_number] => 09/930329
[patent_app_country] => US
[patent_app_date] => 2001-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 11
[patent_no_of_words] => 5400
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 141
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/852/06852846.pdf
[firstpage_image] =>[orig_patent_app_number] => 09930329
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/930329 | Viral amplification of recombinant messenger RNA in transgenic plants | Aug 13, 2001 | Issued |
Array
(
[id] => 6623416
[patent_doc_number] => 20020065324
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-30
[patent_title] => 'Methods of inducing ovulation'
[patent_app_type] => new
[patent_app_number] => 09/928268
[patent_app_country] => US
[patent_app_date] => 2001-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 8389
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20020065324.pdf
[firstpage_image] =>[orig_patent_app_number] => 09928268
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/928268 | Methods of inducing ovulation | Aug 9, 2001 | Abandoned |
Array
(
[id] => 6567063
[patent_doc_number] => 20020165129
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-07
[patent_title] => 'Peptides and their use to ameliorate cell death'
[patent_app_type] => new
[patent_app_number] => 09/919703
[patent_app_country] => US
[patent_app_date] => 2001-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9437
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0165/20020165129.pdf
[firstpage_image] =>[orig_patent_app_number] => 09919703
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/919703 | Peptides and their use to ameliorate cell death | Jul 30, 2001 | Issued |
Array
(
[id] => 654739
[patent_doc_number] => 07109162
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-09-19
[patent_title] => 'Plant derived antioxidants'
[patent_app_type] => utility
[patent_app_number] => 10/343771
[patent_app_country] => US
[patent_app_date] => 2001-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5832
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/109/07109162.pdf
[firstpage_image] =>[orig_patent_app_number] => 10343771
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/343771 | Plant derived antioxidants | Jul 30, 2001 | Issued |
Array
(
[id] => 7634715
[patent_doc_number] => 06656903
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-12-02
[patent_title] => 'Baby food stimulating growth of the thymus'
[patent_app_type] => B1
[patent_app_number] => 09/856483
[patent_app_country] => US
[patent_app_date] => 2001-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2148
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/656/06656903.pdf
[firstpage_image] =>[orig_patent_app_number] => 09856483
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/856483 | Baby food stimulating growth of the thymus | Jul 15, 2001 | Issued |
Array
(
[id] => 1177911
[patent_doc_number] => 06743771
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-06-01
[patent_title] => 'Methods and compositions for controlling protein assembly or aggregation'
[patent_app_type] => B2
[patent_app_number] => 09/904987
[patent_app_country] => US
[patent_app_date] => 2001-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 14
[patent_no_of_words] => 14137
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/743/06743771.pdf
[firstpage_image] =>[orig_patent_app_number] => 09904987
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/904987 | Methods and compositions for controlling protein assembly or aggregation | Jul 11, 2001 | Issued |
Array
(
[id] => 6016006
[patent_doc_number] => 20020102685
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-01
[patent_title] => 'Novel use of inhibitors of the epidermal growth factor receptor'
[patent_app_type] => new
[patent_app_number] => 09/899571
[patent_app_country] => US
[patent_app_date] => 2001-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 11691
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0102/20020102685.pdf
[firstpage_image] =>[orig_patent_app_number] => 09899571
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/899571 | Novel use of inhibitors of the epidermal growth factor receptor | Jul 5, 2001 | Abandoned |